Clinical features of eosinophilia myalgia syndrome and related disorders.
EMS, EF, and TOS are all relatively rare disorders. There are considerable data to suggest that most (if not all) of these cases may be due to toxin exposure, although the precise etiologic agent(s) has yet to be identified. It is likely that the pathogenic mechanisms responsible for disease are similar in these entities, and thus the distinctions between these illnesses may be largely semantic. Rational therapy includes the removal of an inciting agent if identified, and the application of symptom-based treatment based on the organ or tissue involved, and whether there is evidence of active inflammation is present.
Clauw
D J
DJ
Georgetown University Medical Center, Washington, D.C. 20007, USA.
D001937:Brassica; D003240:Connective Tissue Diseases / Q000453:epidemiology* / Q000209:etiology / Q000628:therapy; D004802:Eosinophilia / Q000453:epidemiology* / Q000209:etiology / Q000628:therapy; D016603:Eosinophilia-Myalgia Syndrome / Q000453:epidemiology* / Q000503:physiopathology* / Q000628:therapy; D005229:Fatty Acids, Monounsaturated; D006801:Humans; D010938:Plant Oils / Q000506:poisoning; D000074262:Rapeseed Oil; D013030:Spain / Q000453:epidemiology; D013577:Syndrome
D005229:Fatty Acids, Monounsaturated; D010938:Plant Oils; D000074262:Rapeseed Oil